1. Primary Care Practitioner Perceptions on the Follow-up of Abnormal Cancer Screening Test Results
- Author
-
Steven J. Atlas, Anna N. A. Tosteson, Timothy E. Burdick, Adam Wright, Erica S. Breslau, Tin H. Dang, Amy J. Wint, Rebecca E. Smith, Kimberly A. Harris, Li Zhou, and Jennifer S. Haas
- Subjects
Lung Neoplasms ,Primary Health Care ,Humans ,Breast Neoplasms ,Female ,General Medicine ,Early Detection of Cancer ,Follow-Up Studies - Abstract
ImportanceHealth care systems focus on delivering routine cancer screening to eligible individuals, yet little is known about the perceptions of primary care practitioners (PCPs) about barriers to timely follow-up of abnormal results.ObjectiveTo describe PCP perceptions about factors associated with the follow-up of abnormal breast, cervical, colorectal, and lung cancer screening test results.Design, Setting, and ParticipantsSurvey study of PCPs from 3 primary care practice networks in New England between February and October 2020, prior to participating in a randomized clinical trial to improve follow-up of abnormal cancer screening test results. Participants were physicians and advanced practice clinicians from participating practices.Main Outcomes and MeasuresSelf-reported process, attitudes, knowledge, and satisfaction about the follow-up of abnormal cancer screening test results.ResultsOverall, 275 (56.7%) PCPs completed the survey (range by site, 34.9%-71.9%) with more female PCPs (61.8% [170 of 275]) and general internists (73.1% [201 of 275]); overall, 28,7% (79 of 275) were aged 40 to 49 years. Most PCPs felt responsible for managing abnormal cancer screening test results with the specific cancer type being the best factor (range, 63.6% [175 of 275] for breast to 81.1% [223 of 275] for lung; P Conclusions and RelevanceIn this survey study of PCPs, important deficiencies in systems for managing abnormal cancer screening test results were reported. These findings suggest a need for comprehensive organ-agnostic systems to promote timely follow-up of abnormal cancer screening results using a primary care–focused approach across the range of cancer screening tests.
- Published
- 2022